5,756
Views
67
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Qigong for cancer treatment: A systematic review of controlled clinical trials

, , &
Pages 717-722 | Received 11 Jan 2007, Published online: 08 Jul 2009

References

  • World Health Organization. Cancer control: Knowledge into action: WHO guide for effective programmes. Geneva: World Health Organization; 2006.
  • Wong R, Sagar CM, Sagar SM. Integration of Chinese medicine into supportive cancer care: A modern role for an ancient tradition. Cancer Treat Rev 2001; 27: 235–46
  • National Center for Complementary and Alternative Medicine. Cancer and complementary and alternative medicine. (Available at http://nccam.nih.gov/health/camcancer/) Accessibility verified January 11, 2007. .
  • Dy GK, Bekele L, Hanson LJ, Furth A, Mandrekar S, Sloan JA, et al. Complementary and alternative medicine use by patients enrolled onto phase I clinical trials. J Clin Oncol 2004; 22: 4810–5
  • Frenkel M, Ben-Arye E, Baldwin CD, Sierpina V. Approach to communicating with patients about the use of nutritional supplements in cancer care. South Med J 2005; 98: 289–94
  • Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000; 18: 2505–14
  • Sancier KM. Medical applications of qigong. Altern Ther Health Med 1996; 2: 40–6
  • Chen K, Yeung R. Exploratory studies of Qigong therapy for cancer in China. Integr Cancer Ther 2002; 1: 345–70
  • Sancier KM. Therapeutic benefits of qigong exercises in combination with drugs. J Altern Complement Med 1999; 5: 383–9
  • Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Control Clin Trials 1996; 17: 1–12
  • Fu JZ (1996) , Fu SL, Qin JT. Effect of qigong and anticancer body-building herbs on the prognosis of postoperative patients with cardiac adenocarcinoma. In: Third World Conference on Medical Qigong; 1996. , Beijing, China: .
  • Fu JZ, Wang SM. Qigong plus herbal medicine in treating late-stage stomach cancer in the elderly. Understanding of true qi cultivation and sublimation, ZP Lin. Chinese Publisher of Constructive Materials, BeijingChina 1995; 155–7
  • Hong EY. The effect of Yudongkong exercise in fatigue, difficulty of daily activities and symptoms of side effect in advanced gastric cancer patients receiving chemotherapy. PhD dissertion. SeoulKorea: Yonsei University; 2003.
  • Lam SWY. A randomixed, controlled trial of Guolin qigong in patients receiving tanscatheter arterial chemoembolisation for unresectable hepatocellular carcinoma Master's thesis. Hong Kong: University of Hong Kong; 2004.
  • Lee TI, Chen HH, Yeh ML. Effects of chan-chuang qigong on improving symptom and psychological distress in chemotherapy patients. Am J Chin Med 2006; 34: 37–46
  • Sun QZ (1988) , Zhao L. Clinical observation of qigong as a therapeutic aid for advanced cancer patients. In: First World Conference for Academic Exchange of Medical Qigong; 1988. , Beijing, China: .
  • Wang CH (1993) , Wang BR, Shao MY, Li ZQ. Clinical study if tge routine treatment if cancer coordinated by qigong. In: 2nd World conference for academic exchange of medical qigong, 1993. , Beijing, China: .
  • Wang Y, Ye M. Analysis of psychological err factors in assessment of therapeutic effect of qigong rehabilitaiton in cancer patients. Acta Universitatis Traditionis Medicalis Sinensis Pharmacologiaeque Shanghai 2002; 16: 20–2
  • Zheng RR. Observation of 100 cases with comprehensive qigong therapy for treating later-stage cancer. World Qigong 1990; 3: 19
  • Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA 1990; 263: 1385–9
  • Egger M, Smith GD. Bias in location and selection of studies. BMJ 1998; 316(7124)61–6
  • Ernst E, Pittler MH. Alternative therapy bias. Nature 1997; 385(6616)480
  • Pittler MH, Abbot NC, Harkness EF, Ernst E. Location bias in controlled clinical trials of complementary/alternative therapies. J Clin Epidemiol 2000; 53: 485–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.